The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)

被引：23
作者：
Bay-Jensen, Anne-C [1 ]
Henrotin, Yves [2 ,3 ]
Karsdal, Morten [1 ,4 ]
Mobasheri, Ali [5 ,6 ,7 ,8 ,9 ,10 ]
机构：
[1] Nord Biosci, Rheumatol Biomarkers & Res, Herlev, Denmark
[2] Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium
[3] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium
[4] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England
[5] Univ Southern Denmark, Dept Canc & Inflammat Res, Copenhagen, Denmark
[6] Queens Med Ctr, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nottingham NG7 2UH, England
[7] King Abdulaziz Univ, CEGMR, KFMRC, Jeddah 21413, Saudi Arabia
[8] Queens Med Ctr, Arthrit Res UK Pain Ctr, Nottingham NG7 2UH, England
[9] Queens Med Ctr, MRC, Nottingham NG7 2UH, England
[10] Queens Med Ctr, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Nottingham NG7 2UH, England
来源：
EBIOMEDICINE | 2016年 / 7卷
关键词：
D O I：
10.1016/j.ebiom.2016.05.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 9 条
  • [1] Classification of osteoarthritis biomarkers:: a proposed approach
    Bauer, D. C.
    Hunter, D. J.
    Abramson, S. B.
    Attur, M.
    Corr, M.
    Felson, D.
    Heinegard, D.
    Jordan, J. M.
    Kepler, T. B.
    Lane, N. E.
    Saxne, T.
    Tyree, B.
    Kraus, V. B.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (08) : 723 - 727
  • [2] Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria
    Bay-Jensen, A. C.
    Reker, D.
    Kjelgaard-Petersen, C. F.
    Mobasheri, A.
    Karsdal, M. A.
    Ladel, C.
    Henrotin, Y.
    Thudium, C. S.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2016, 24 (01) : 9 - 20
  • [3] Parallel evolution of OA phenotypes and therapies
    Conaghan, Philip G.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (02) : 68 - 70
  • [4] Karsdal M. A., 2013, OSTEOARTHR CARTIL
  • [5] Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
    Kraus, V. B.
    Burnett, B.
    Coindreau, J.
    Cottrell, S.
    Eyre, D.
    Gendreau, M.
    Gardiner, J.
    Garnero, P.
    Hardin, J.
    Henrotin, Y.
    Heinegard, D.
    Ko, A.
    Lohmander, L. S.
    Matthews, G.
    Menetski, J.
    Moskowitz, R.
    Persiani, S.
    Poole, A. R.
    Rousseau, J. -C.
    Todman, M.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (05) : 515 - 542
  • [6] Kraus V. B., 2015, OSTEOARTHR CARTIL
  • [7] The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
    Mobasheri, A.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)
  • [8] Patterson SD, 2011, PHARMACOGENOMICS, V12, P939, DOI [10.2217/pgs.11.52, 10.2217/PGS.11.52]
  • [9] The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
    Qvist, Per
    Bay-Jensen, Anne-Christine
    Christiansen, Claus
    Dam, Erik B.
    Pastoureau, Philippe
    Karsdal, Morten A.
    [J]. PHARMACOLOGICAL RESEARCH, 2008, 58 (01) : 1 - 7
1